CTI Life Sciences collects C$134 mln for second venture fund
Montreal-based CTI Life Sciences has raised C$134 million in the first close of its second venture fund. The pool's limited partners include Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan. CTI II will invest mostly in biotherapeutics.
15 January 2015•3 mins read
